Pages
-
-
SELNET clinical practice guidelines for soft tissue sarcoma and GIST (vol 102, 102312, 2021)
-
-
Datasets for the reporting of primary tumour in bone
-
-
Datasets for the reporting of primary tumour in bone
-
-
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
-
-
Adjuvant imatinib in patients with GIST harboring exon 9 KIT mutations
-
-
Systemic treatment in advanced phyllodes tumor of the breast
-
-
Systemic treatment in advanced phyllodes tumor of the breast
-
-
Gastrointestinal stromal tumours
-
-
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
-
-
Bone sarcomas
-
-
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
-
-
Ultra-rare sarcomas
-
-
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
-
-
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
-
-
The sacral chordoma margin
-
-
Evolution in the management of soft tissue sarcoma: classification, surgery and use of radiotherapy
-
-
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
-
-
The key role of pathology, surgery and radiotherapy in the initial management of soft tissue sarcoma
-
-
Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group
-
-
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemothe
-
-
Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014)
-
-
Bone Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii113, 2014)
-
-
Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii102, 2014)
-
-
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
Pages